Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
Jianzhong Huang, Jessica J. Kandel, Darrell J. Yamashiro(Columbia University), Stephanie M. Zabski(Regeneron (United States)), Angela Kadenhe(Regeneron (United States)), Jocelyn Holash(Regeneron (United States)), Akiko Yokoi, Anna Serur, George D. Yancopoulos(Regeneron (United States)), Kathleen O’Toole(Regeneron (United States)), John S. Rudge(MedStar Washington Hospital Center), Jason S. Frischer, Tamara New(Columbia University), Kimberly W. McCrudden(Regeneron (United States))
Cited by 225
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763